Aja Beckett, founder of GLP-1 companion app Shotsy, discusses why Shotsy avoids integrating conversational AI chatbots or synthetic companions into its mobile platform.
0:00 / 0:14exact quote · 14.8s
720p mp4 · rendered on demand · StarZero watermark
“I know that we've seen some apps that have experimented with integrating like AI chatbots and AI companions. I don't find that particularly compelling. You know, I think if you want to talk to AI about it, you've got a lot of options for doing that. It doesn't have to be in the app.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
More from Aja Beckett
Opinion
Cultural bias prevents treating weight loss as a normal medical condition
“There's so much bias and judgment that this is not treated like a normal medical condition, I think, in a lot of channels.”
Aja BeckettJun 9, 2026▶ 9:07Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Insight
Legacy diet concepts will fail to resonate with GLP-1 app users
“When we see other apps that seem to be bringing a lot of those concepts into GLP-ONE tracking, I think that's just inherently not going to resonate as much with this community”
Aja BeckettJun 9, 2026▶ 14:30Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Disclosure
Shotsy hit one million downloads and 100,000 active paid subscribers
“We've had we've had over a million downloads. And we have at this point, I think a 100,000 active paid subscribers.”
Aja BeckettJun 9, 2026▶ 11:14Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
AssertionContradicted
Competing GLP-1 companion apps are pivoting to in-app drug marketplaces
“We've actually seen several of the several other apps in our space just recently start to add you know, kind of a marketplace for the drugs themselves within the app.”
Aja BeckettJun 9, 2026▶ 20:49Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Disclosure
Shotsy will maintain vendor independence from pharmacies and telehealth clinics
“My instinct from the beginning has been that there is a lot of value in us maintaining an independent position in the space, right? Like the word, you know, Shotzi is not tied to a particular medication, it's not tied to a particular clinic or pharmacy and it …”
Aja BeckettJun 9, 2026▶ 21:08Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Insight
Keeping a day job improves early-stage startup decision-making and creativity
“Things got so much easier once I did take a day job and start bringing in some regular income instead of trying to constantly you know, force my, you know, fledgling businesses to try to support me financially. I think that's something that would have made it …”
Aja BeckettJun 9, 2026▶ 39:35Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 100 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.